Therapeutic Radiopharmaceuticals (Therapeutic Radiopharmaceuticals)


Indications and Reactions:

Role Indications Reactions
Secondary
Oesophageal Carcinoma 36.2%
Oesophageal Squamous Cell Carcinoma 10.8%
Rectal Cancer 9.8%
Cervix Carcinoma 7.0%
Anal Squamous Cell Carcinoma 6.3%
Anal Cancer 4.8%
Hypopharyngeal Cancer 4.0%
Cervix Carcinoma Stage Iv 2.8%
Gastric Cancer 2.8%
Gallbladder Cancer 2.5%
Breast Cancer 2.3%
Squamous Cell Carcinoma 2.0%
Adenocarcinoma Pancreas 1.5%
Bladder Cancer 1.3%
Lip And/or Oral Cavity Cancer 1.0%
Neuroblastoma 1.0%
Oesophageal Squamous Cell Carcinoma Stage Ii 1.0%
Rectal Cancer Stage Iii 1.0%
Squamous Cell Carcinoma Of Head And Neck 1.0%
Squamous Cell Carcinoma Of The Oral Cavity 1.0%
Toxicity To Various Agents 10.3%
Anaemia 8.0%
Leukopenia 8.0%
Thrombocytopenia 8.0%
Neutropenia 6.9%
Oesophagitis 6.9%
Vomiting 6.9%
Death 5.7%
Fistula 4.6%
Acute Lymphocytic Leukaemia 3.4%
Diarrhoea 3.4%
Fatigue 3.4%
Febrile Neutropenia 3.4%
Oesophageal Stenosis 3.4%
Pericardial Effusion 3.4%
Sepsis 3.4%
White Blood Cell Count Decreased 3.4%
Mucosal Inflammation 2.3%
Myocardial Infarction 2.3%
Nausea 2.3%
Concomitant
Hypopharyngeal Cancer 13.9%
Oesophageal Carcinoma 11.1%
Rectal Cancer Stage Iii 11.1%
Adenocarcinoma 8.3%
Breast Cancer Stage I 8.3%
Chemotherapy 8.3%
Squamous Cell Carcinoma 8.3%
Nasopharyngeal Cancer 5.6%
Oligodendroglioma 5.6%
Rectal Adenocarcinoma 5.6%
Glioma 2.8%
Ill-defined Disorder 2.8%
Neuralgia 2.8%
Off Label Use 2.8%
Rectal Cancer Stage Ii 2.8%
Death 5.9%
Electrocardiogram T Wave Abnormal 5.9%
Electrocardiogram T Wave Inversion 5.9%
Glomerulonephritis Rapidly Progressive 5.9%
Loose Tooth 5.9%
Mucosal Inflammation 5.9%
Neuropathy Peripheral 5.9%
Neutropenia 5.9%
Off Label Use 5.9%
Platelet Count Decreased 5.9%
Pneumonia Aspiration 5.9%
Pyrexia 5.9%
Renal Impairment 5.9%
Sensory Loss 5.9%
Troponin Increased 5.9%
Visual Acuity Reduced 5.9%
Vomiting 5.9%

Drug Data